Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
A

ABUS

Nasdaq

Arbutus Biopharma Corp

Latest disclosureOctober 7, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 0 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 27

Limited filing history
All27Buying0Selling0Other27
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

27 trades · June 8, 2026 – October 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 27 trades on this page.

Other activity disclosed

Robert A. Beardsley

Director

Common Shares

Value context
$89.74K
Reported price
$5.00 / share
Traded October 1, 2026Filed October 7, 2026SEC filing
Other activity disclosed

Tuan Nguyen

Chief Financial Officer

Common Shares

Value context
$240.41K
Reported price
$5.00 / share
Traded October 1, 2026Filed October 7, 2026SEC filing
Other activity disclosed

Roger Sawhney

Director

Common Shares

Value context
$85.71K
Reported price
$5.00 / share
Traded October 1, 2026Filed October 7, 2026SEC filing
Other activity disclosed

Lindsay Androski

President and CEO

Common Shares

Value context
$123.28K
Reported price
$5.00 / share
Traded October 1, 2026Filed October 7, 2026SEC filing
Other activity disclosed

Sciences Roivant

Director

Common Shares

Value context
$44.84M
Reported price
$5.00 / share
Traded October 1, 2026Filed October 5, 2026SEC filing
Exercise or conversion

Lindsay Androski

President and CEO

Common Shares

Value context
$372.51K
Reported price
$3.20 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Lindsay Androski

President and CEO

Common Shares

Value context
$45.9K
Reported price
$4.39 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Tax or exercise withholding

Lindsay Androski

President and CEO

Common Shares

Value context
$418.41K
Reported price
$5.07 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Lindsay Androski

President and CEO

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.20 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Lindsay Androski

President and CEO

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.39 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Tuan Nguyen

Chief Financial Officer

Common Shares

Value context
$927.03K
Reported price
$3.49 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Tuan Nguyen

Chief Financial Officer

Common Shares

Value context
$120.62K
Reported price
$4.39 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Tax or exercise withholding

Tuan Nguyen

Chief Financial Officer

Common Shares

Value context
$1.05M
Reported price
$5.07 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Tuan Nguyen

Chief Financial Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.49 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Tuan Nguyen

Chief Financial Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.39 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Roger Sawhney

Director

Common Shares

Value context
$175.46K
Reported price
$3.34 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Roger Sawhney

Director

Common Shares

Value context
$334.11K
Reported price
$4.24 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Tax or exercise withholding

Roger Sawhney

Director

Common Shares

Value context
$509.58K
Reported price
$5.07 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Roger Sawhney

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.34 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Roger Sawhney

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.24 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Robert A. Beardsley

Director

Common Shares

Value context
$168.11K
Reported price
$3.20 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Robert A. Beardsley

Director

Common Shares

Value context
$334.11K
Reported price
$4.24 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Tax or exercise withholding

Robert A. Beardsley

Director

Common Shares

Value context
$502.22K
Reported price
$5.07 / share
Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Robert A. Beardsley

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$3.20 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Exercise or conversion

Robert A. Beardsley

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.24 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 18, 2026Filed September 23, 2026SEC filing
Award disclosed

Roger Sawhney

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 8, 2026Filed June 10, 2026SEC filing
Award disclosed

Robert A. Beardsley

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 8, 2026Filed June 10, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorCommon SharesDisposition to issuer17,948$5.00 / share$89.74KOct 1Filed Oct 7 · 6d laterSEC filing
Chief Financial OfficerCommon SharesDisposition to issuer48,081$5.00 / share$240.41KOct 1Filed Oct 7 · 6d laterSEC filing
DirectorCommon SharesDisposition to issuer17,142$5.00 / share$85.71KOct 1Filed Oct 7 · 6d laterSEC filing
President and CEOCommon SharesDisposition to issuer24,655$5.00 / share$123.28KOct 1Filed Oct 7 · 6d laterSEC filing
DirectorCommon SharesDisposition to issuer8,967,383$5.00 / share$44.84MOct 1Filed Oct 5 · 4d laterSEC filing
President and CEOCommon SharesOption exercise or conversion116,408$3.20 / share$372.51KSep 18Filed Sep 23 · 5d laterSEC filing
President and CEOCommon SharesOption exercise or conversion10,456$4.39 / share$45.9KSep 18Filed Sep 23 · 5d laterSEC filing
President and CEOCommon SharesExercise-price or tax withholding82,527$5.07 / share$418.41KSep 18Filed Sep 23 · 5d laterSEC filing
President and CEOStock Option (Right to Buy)Option exercise or conversionDerivative units116,408$3.20 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
President and CEOStock Option (Right to Buy)Option exercise or conversionDerivative units10,456$4.39 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
Chief Financial OfficerCommon SharesOption exercise or conversion265,625$3.49 / share$927.03KSep 18Filed Sep 23 · 5d laterSEC filing
Chief Financial OfficerCommon SharesOption exercise or conversion27,475$4.39 / share$120.62KSep 18Filed Sep 23 · 5d laterSEC filing
Chief Financial OfficerCommon SharesExercise-price or tax withholding206,637$5.07 / share$1.05MSep 18Filed Sep 23 · 5d laterSEC filing
Chief Financial OfficerStock Option (Right to Buy)Option exercise or conversionDerivative units265,625$3.49 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
Chief Financial OfficerStock Option (Right to Buy)Option exercise or conversionDerivative units27,475$4.39 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
DirectorCommon SharesOption exercise or conversion52,533$3.34 / share$175.46KSep 18Filed Sep 23 · 5d laterSEC filing
DirectorCommon SharesOption exercise or conversion78,800$4.24 / share$334.11KSep 18Filed Sep 23 · 5d laterSEC filing
DirectorCommon SharesExercise-price or tax withholding100,508$5.07 / share$509.58KSep 18Filed Sep 23 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Option exercise or conversionDerivative units52,533$3.34 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Option exercise or conversionDerivative units78,800$4.24 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
DirectorCommon SharesOption exercise or conversion52,533$3.20 / share$168.11KSep 18Filed Sep 23 · 5d laterSEC filing
DirectorCommon SharesOption exercise or conversion78,800$4.24 / share$334.11KSep 18Filed Sep 23 · 5d laterSEC filing
DirectorCommon SharesExercise-price or tax withholding99,057$5.07 / share$502.22KSep 18Filed Sep 23 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Option exercise or conversionDerivative units52,533$3.20 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Option exercise or conversionDerivative units78,800$4.24 exercise / conversion priceNot a separate purchaseSep 18Filed Sep 23 · 5d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units78,800Award · no purchase priceNon-cash awardJun 8Filed Jun 10 · 2d laterSEC filing
DirectorStock Option (Right to Buy)Grant or awardDerivative units78,800Award · no purchase priceNon-cash awardJun 8Filed Jun 10 · 2d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for ABUS in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001447028
Latest public acceptance
Oct 7, 2026, 08:12 PM UTC
Score calculated
Oct 8, 2026, 12:06 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.